Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Letter to Gillian Keegan about the use of mobile phones in schools
Dear Secretary of State,
I am writing to you following your announcement that the Government is looking to ban mobile phones in school.
Around thirty thousand children in the UK live with type 1 diabetes. Continuous glucose monitoring and insulin dosage is delivered, for the vast majority of these children, via their mobile phone.
Insulin is a hormone which the body needs in order to convert glucose from food into energy. In type 1 diabetes the body does not produce insulin, meaning people need to administer insulin frequently at all times of day and night. A range of factors will cause potentially serious blood glucose highs and lows including food intake, exercise, tiredness, adrenaline.
Mobile phones are not just a form of communication for children living with type 1. Their phones are a lifesaving treatment device, recommended by the NHS and regulators to reduce potentially fatal high and low blood glucose spikes. They need their phones in exams, in the playground, in lessons, at lunch and during PE. There are agreed rules and processes to support children in all these circumstances.
Headline policies about banning mobile phones for children do not take into account advances in medical treatments and technologies, and blanket statements that offer little to no detail on exemptions can cause great consternation for parents and children with type 1.
I trust that such exemptions will be allowed and that you will make these known in due course.
I look forward to your reply.
Chief Executive, JDRF, the Type 1 Diabetes Charity
Managing type 1 after a new diagnosis can be a steep learning curve. Our guide covers managing your child’s type 1, treatment and technology for children and how to manage all stages of your child’s education.
Learn about the different types of tech for monitoring blood glucose levels and getting insulin into your child’s body. Find out how to access type 1 tech on the NHS and learn from others’ stories.
Continuous glucose monitoring can help you manage your glucose levels in real-time and relieve the burden of having to do multiple finger prick tests throughout the day. Learn more about this tech.
As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.
Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.
Abbott has announced that its FreeStyle Libre® 3 sensor is now authorised to work with Ypsomed’s mylife™ YpsoPump and CamDiab’s CamAPS FX mobile app.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.